Login to Your Account

DFMO Rises Again

Combo Drug's Phase III Trial Aims to Prevent Colon Cancer

By Randy Osborne
Staff Writer

Friday, April 19, 2013
Cancer Prevention Pharmaceuticals Inc. (CPP) is trying out its tumor-blocking approach in colon adenomas by way of a Phase III trial in a collaborative effort with the National Cancer Institute (NCI) that will enroll 1,340 survivors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription